CEO & Chairman, 10% Owner of Emergent BioSolutions Inc. (EBS, Financial) Fuad El-hibri sells 161,700 shares of EBS on 09/16/2009 at an average price of $19.63 a share.
EMERGENT BIOSULUTIONS INC. is a leading biopharmaceutical company dedicated to one simple mission - to protect life. EBS develops manufactures and commercializes vaccines and therapeutics that assist the body's immune system to prevent or treat disease. Their products target infectious diseases and other medical conditions that have resulted in significant unmet or underserved public health needs. Their marketed product BioThrax? (Anthrax Vaccine Adsorbed) is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent Biosolutions Inc. has a market cap of $587.4 million; its shares were traded at around $19.29 with a P/E ratio of 15 and P/S ratio of 3.3.
Recent Trades of Emergent BioSolutions Inc. by CEO:
Recent Trades of Emergent BioSolutions Inc. by Directors and Officers:
EMERGENT BIOSULUTIONS INC. is a leading biopharmaceutical company dedicated to one simple mission - to protect life. EBS develops manufactures and commercializes vaccines and therapeutics that assist the body's immune system to prevent or treat disease. Their products target infectious diseases and other medical conditions that have resulted in significant unmet or underserved public health needs. Their marketed product BioThrax? (Anthrax Vaccine Adsorbed) is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent Biosolutions Inc. has a market cap of $587.4 million; its shares were traded at around $19.29 with a P/E ratio of 15 and P/S ratio of 3.3.
Recent Trades of Emergent BioSolutions Inc. by CEO:
- Sell: CEO & Chairman, 10% Owner Fuad El-hibri sold 75,500 shares of EBS stock on 09/11/2009 at the average price of $19.36; the price of the stock has decreased by 0.36% since.
- Sell: CEO & Chairman, 10% Owner Fuad El-hibri sold 15,000 more shares of EBS stock on 08/11/2009 at the average price of $16.78; the price of the stock has increased by 14.96% since.
Recent Trades of Emergent BioSolutions Inc. by Directors and Officers:
- Sell: Director Sue Bailey sold 10,000 shares of EBS stock on 09/11/2009 at the average price of $19.21; the price of the stock has increased by 0.42% since.
- Sell: President & COO Daniel Abdun-nabi sold 2,000 shares of EBS stock on 08/18/2009 at the average price of $16.27; the price of the stock has increased by 18.56% since.
- Sell: President Daniel Abdun-nabi sold 11,000 more shares of EBS stock on 08/11/2009 at the average price of $17.23; the price of the stock has increased by 11.96% since.
- Sell: Director Zsolt Harsanyi sold 4,086 shares of EBS stock on 08/07/2009 at the average price of $15.45; the price of the stock has increased by 24.85% since.
- Sell: Director Zsolt Harsanyi sold 14,296 more shares of EBS stock on 07/30/2009 at the average price of $15.05; the price of the stock has increased by 28.17% since.
